Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study.
Turnes J, Rincón D, Calleja JL, Delgado MB, Rosales JM, Andrade RJ, Manzano ML, Salmerón FJ, López MA, Calvo M, Gómez J, Molina E, Frias YN, Gálvez-Fernández RM, Vallejo-Senra N, París S, Santos de Lamadrid R, Olveira A.
Turnes J, et al. Among authors: delgado mb.
Gastroenterol Hepatol. 2022 May;45(5):342-349. doi: 10.1016/j.gastrohep.2021.05.015. Epub 2021 Jun 12.
Gastroenterol Hepatol. 2022.
PMID: 34129903
English, Spanish.